Science at Our Facilities

Enabling your science to advance patient health

icon of a map
A network of locations just minutes from your lab
Find a Mispro facility near you

Your research can pivot quickly.
So can we.

Our flex-lab facilities, streamlined processes, and expert services keep your research moving forward

Research areas we support

Mispro offers access to state-of-the-art vivarium facilities for early-stage non-GLP in vivo drug development studies. Our clients span a range of research fields, including:

  • Oncology
  • Neurology, Psychiatry, and Substance Abuse
  • Immunology and Vaccines
  • Gene Therapy/Editing
  • Gastroenterology (GI)
  • Cardiovascular
  • Endocrinology
  • Dermatology
  • Hepatology
  • Ophthalmology

Mispro offers Biosafety level 1 (BSL-1) and Biosafety level 2 (BSL-2) research environments for early-stage preclinical non-GLP pharmacology, safety tox, and efficacy studies with mice and rat models. Common in vivo study designs we support in our vivarium research facilities include:

  • Non-GLP preclinical safety tox
  • Efficacy
  • Pharmacokinetics (PK) and Pharmacodynamics (PD)
  • ADME
  • Target validation
  • Metabolism
  • Viral challenge
  • Library target screening
  • Behavioral Assay
  • Surgery

Mispro's mission is to enable innovations in science by giving founding scientists control over their studies in a world-class research environment and with best-in-class supporting services for laboratory animal research.

Mispro provides an optimal research environment for companies pursuing novel, innovative, and proprietary therapeutic modalities and drug delivery systems. Whether your lab is on the cutting edge of gene therapies, viral vectors, or focused on innovative small and large molecule delivery systems, our team of specialists can work with you to equip your space and develop study protocols to support your customized approach.

Our clients are pursuing advancements in drug and therapeutic product development across multiple pathways, including:

  • Cell therapies
  • CAR T cell therapies
  • Stem cell/human induced pluripotent cell therapies
  • Gene therapies
  • Gene editing therapies (including CRISPR technologies)
  • Oncolytic viruses
  • Microsomes
  • Bacteria as therapeutic agents
  • Bacteriophage therapeutics
  • Viral mediated therapies
  • Protein therapeutics
  • Nanomaterials
  • Synthetic vesicles
  • Immuno therapies
  • Viral mediated therapies

Flex-lab vivarium space for companies at different stages of development

Frequently asked questions
Does Mispro provide animal models for studies?
faq expand icon

Clients establish their own accounts with animal vendors. At the client’s request, Mispro can manage ordering and receiving animals for a client once an account is set up.

What biosafety level is supported in Mispro facilities?
faq expand icon

Mispro supports biosafety level (BSL) I and biosafety level (BSL) II studies in our facilities.

Does Mispro support behavioral studies?
faq expand icon

Yes, clients can conduct behavioral studies in our facilities but must provide any special equipment and/or caging that is specific to the study.

What types of animal models can I use in my research?
faq expand icon

Mispro primarily supports rodent studies with immuno-competent and immuno-compromised models. Please inquire with us about other animal models.

Does Mispro offer technical services support?
faq expand icon

Yes. Mispro offers both training and assistance for basic biomethodology, surgical procedure support, and breeding colony management in support of preclinical in vivo rodent studies.

How can I ensure that our studies will remain confidential?
faq expand icon

Confidentiality is central to Mispro’s mission and we ensure that sensitive information is not displayed on rooms, cages, or racks. Private animal housing and procedure rooms are exclusive to your company with the exception of Mispro’s professional staff who enter to provide care and maintenance. Shared procedure rooms contain locked storage areas for equipment and proprietary materials.

Learn More
Download our latest whitepaper